LIC Nivesh Plus Plan 849 (Plan 749) Details

LIC Nivesh Plus Plan 849 (Plan 749) Details

LIC Nivesh Plus Plan 849 (Earlier Plan 749)

Plan Overview

LIC Nivesh Plus is a non-linked, non-participating individual savings plan that offers guaranteed benefits with flexibility in premium payment terms.

Key Features

Feature Details
Plan Type Savings plan with guaranteed returns
Policy Term 10 to 25 years (as chosen by policyholder)
Premium Payment Term Single pay or Regular pay (5, 7, or 10 years)
Minimum Age at Entry 90 days (completed)
Maximum Age at Entry 60 years (for 10-year term) to 50 years (for 25-year term)
Minimum Sum Assured ₹1,00,000 (varies by premium payment term)
Maximum Sum Assured No limit (subject to underwriting)

Benefits

Death Benefit

Higher of:

  • 10 times annualized premium (for regular pay)
  • 1.25 times single premium (for single pay)
  • 105% of all premiums paid

Maturity Benefit

Guaranteed maturity amount = Sum Assured + Guaranteed Additions

Guaranteed Additions accrue at the following rates:

Policy Term Guaranteed Addition Rate (per ₹1,000 SA)
10 years ₹60
15 years ₹75
20 years ₹90
25 years ₹105

Example Illustration

Parameter Example
Policyholder Age 35 years
Sum Assured ₹5,00,000
Policy Term 15 years
Premium Payment Term 10 years
Annual Premium ₹48,500 (approx)
Total Premium Paid ₹4,85,000
Guaranteed Additions ₹75 per ₹1,000 SA = ₹37,500 per year × 15 years = ₹5,62,500
Maturity Benefit ₹5,00,000 (SA) + ₹5,62,500 (GA) = ₹10,62,500

Additional Features

  • Loan Facility: Available after 3 policy years
  • Surrender Value: Available after 2 full years' premiums
  • Tax Benefits: Premiums eligible under Section 80C, benefits under Section 10(10D)

Eligibility Conditions

Condition Requirement
Minimum Entry Age 90 days
Maximum Entry Age 60 years (varies by term)
Minimum Sum Assured ₹1,00,000 (₹2,00,000 for 5-year PPT)
Maximum Maturity Age 75 years

Note: This plan is now marketed as Plan 849 (earlier Plan 749). Features remain largely similar with minor modifications.

Post a Comment

0 Comments